Oncology & Cancer

Multigene testing for all breast cancer patients cost-effective

(HealthDay)—Unselected, multigene testing for all patients with breast cancer would be cost-effective in the United Kingdom and the United States, according to a study published online Oct. 3 in JAMA Oncology.

Oncology & Cancer

Screening for lung cancer based on risk could save lives

Changing the way individuals are selected to be screened for lung cancer, by considering their probability of getting or dying from lung cancer calculated from risk-prediction models, could prevent 14 percent of lung cancer ...

Health

Web tool prioritizes health risks for postmenopausal women

A web-based calculator that helps middle-aged women predict their risks of conditions that become more likely with age has been developed by public health, medical and computer science experts from throughout the U.S. and ...

Oncology & Cancer

Ovarian cancer can be a silent killer

September is National Ovarian Cancer Awareness Month. Ovarian cancer is a group of diseases that originates in the ovaries or in the related areas of the fallopian tubes and the peritoneum. This disease is sometimes known ...

Genetics

Undiagnosed diseases program finds novel genetic variant

The Undiagnosed Diseases Program at the University of Alabama at Birmingham recently found a previously unknown genetic variant that is believed to account for a severe movement disorder in a young woman. In a case study ...

page 1 from 23